|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: TANKNOLOGY NDE INTERNATIONAL INC, 10-Q/A, 1999-05-21 |
Next: AMERICAN ASSET MANAGEMENT CORP, 10QSB, 1999-05-21 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
[X] Amendment to Quarterly report pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 for the quarterly period ended April 3,
1999 or
[ ] Transition report pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 for the transition period from _____________ to
_____________.
Commission file number 0-17885
BEI MEDICAL SYSTEMS COMPANY, INC.
(Exact name of Registrant as specified in its charter)
Delaware 71-0455756
- ----------------------- ----------------------------------
(State of incorporation) (I.R.S. Employer Identification No.)
100 Hollister Road
Teterboro, New Jersey 07608
---------------------------
(Address of principal executive offices)
(201) 727-4900
(Registrant's telephone number)
Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the Registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes _X_ No ___
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.
Common Stock: $.001 Par Value, 7,687,596 shares as of May 1, 1999
1
<PAGE>
BEI MEDICAL SYSTEMS COMPANY, INC. AND SUBSIDIARIES
INDEX
PART II. OTHER INFORMATION
-----------------
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibits
27.1 Financial Data Schedule
SIGNATURES
----------
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized on May 21, 1999.
BEI Medical Systems Company, Inc.
By: /s/ Thomas W. Fry
---------------------------------------------
Thomas W. Fry
Vice President of Finance and Administration,
Secretary and Treasurer
(Chief Financial Officer)
3
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED APRIL 3, 1999
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> OCT-02-1999
<PERIOD-START> OCT-04-1998
<PERIOD-END> APR-03-1999
<CASH> 2,780
<SECURITIES> 0
<RECEIVABLES> 1,568
<ALLOWANCES> (165)
<INVENTORY> 3,029
<CURRENT-ASSETS> 7,824
<PP&E> 1,622
<DEPRECIATION> (931)
<TOTAL-ASSETS> 13,598
<CURRENT-LIABILITIES> 2,264
<BONDS> 0
0
0
<COMMON> 10
<OTHER-SE> 11,324
<TOTAL-LIABILITY-AND-EQUITY> 13,598
<SALES> 4,165
<TOTAL-REVENUES> 4,228
<CGS> 2,489
<TOTAL-COSTS> 5,128
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (3,389)
<INCOME-TAX> (208)
<INCOME-CONTINUING> (3,181)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,181)
<EPS-PRIMARY> (0.42)
<EPS-DILUTED> (0.42)
</TABLE>
|
|